Its less invasive and easier to integrate into a nightly routine
Clinical presentation and possible contributing factors to SGLT2 inhibitor-associated DKA Nausea and vomiting were the most common presenting symptoms of SGLT2 inhibitor-associated DKA, followed by general weakness, dyspnea, abdominal pain, and mental changes (Table 2)
It's worth noting that using sterile, FDA-approved injection devices for prescribed medications is not itself a reason for deferral
doi: 10.1016/j.ctim.2016.01.009 134 BiswalBMZakariaAAhmadNM
Rybelsus may interact with other medications, including insulin or sulfonylureas, leading to hypoglycemia
CJC-1295 Mechanism: CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone with specific changes that enhance its shelf life and potency